Suppr超能文献

澳大利亚和新西兰重症监护病房收治的蛛网膜下腔出血患者:15 年住院死亡率的多中心队列分析。

Subarachnoid Hemorrhage Patients Admitted to Intensive Care in Australia and New Zealand: A Multicenter Cohort Analysis of In-Hospital Mortality Over 15 Years.

机构信息

1Department of Intensive Care and Hyperbaric Medicine, The Alfred, Prahran, Melbourne, VIC, Australia. 2Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, The Alfred Centre, Prahran, Melbourne, VIC, Australia. 3Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, Australia. 4Intensive Care Unit, Royal North Shore Hospital, St Leonards, NSW, Australia. 5Northern Clinical School, Sydney Medical School, University of Sydney, St. Leonards, NSW, Australia. 6Intensive Care Unit, Sir Charles Gairdner Hospital, Nedlands, WA, Australia. 7Intensive Care Unit, The Austin Hospital, Heidelberg, Melbourne, VIC, Australia. 8Centre for Outcome and Resource Evaluation, Australian and New Zealand Intensive Care Society, Carlton South, Melbourne, VIC, Australia.

出版信息

Crit Care Med. 2017 Feb;45(2):e138-e145. doi: 10.1097/CCM.0000000000002059.

Abstract

OBJECTIVE

The primary aim of this study was to describe in-hospital mortality in subarachnoid hemorrhage patients requiring ICU admission. Secondary aims were to identify clinical characteristics associated with inferior outcomes, to compare subarachnoid hemorrhage mortality with other neurological diagnoses, and to explore the variability in subarachnoid hemorrhage standardized mortality ratios.

DESIGN

Multicenter, binational, retrospective cohort study.

SETTING

Data were extracted from the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation Adult Patient Database.

PATIENTS

All available records for the period January 2000 to June 2015.

INTERVENTIONS

Nil.

MEASUREMENTS AND MAIN RESULTS

A total of 11,327 subarachnoid hemorrhage patients were identified in the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation Adult Patient Database. The overall case fatality rate was 29.2%, which declined from 35.4% in 2000 to 27.2% in 2015 (p = 0.01). Older age, nonoperative admission, mechanical ventilation, higher Acute Physiology and Chronic Health Evaluation III scores, lower Glasgow Coma Scale, and admission prior to 2004 were all associated with lower hospital survival in multivariable analysis (p < 0.05). In comparison with other neurological diagnoses, subarachnoid hemorrhage patients had significantly greater risk-adjusted in-hospital mortality (odds ratio, 1.89 [95% CI, 1.79-2.00]). Utilizing data from the 5 most recent complete years (2010-2014), three sites had higher and four (including the two largest centers) had lower standardized mortality ratios than might be expected due to chance.

CONCLUSIONS

Subarachnoid hemorrhage patients admitted to ICU in Australia and New Zealand have a high mortality rate. Year of admission beyond 2003 did not impact risk-adjusted in-hospital mortality. Significant variability was noted between institutions. This implies an urgent need to systematically evaluate many aspects of the critical care provided to this patient group.

摘要

目的

本研究的主要目的是描述需要入住 ICU 的蛛网膜下腔出血患者的院内死亡率。次要目的是确定与预后不良相关的临床特征,将蛛网膜下腔出血的死亡率与其他神经学诊断进行比较,并探讨蛛网膜下腔出血标准化死亡率的变异性。

设计

多中心、两国回顾性队列研究。

设置

数据从澳大利亚和新西兰重症监护学会中心结果和资源评估成人患者数据库中提取。

患者

2000 年 1 月至 2015 年 6 月期间的所有可用记录。

干预措施

无。

测量和主要结果

澳大利亚和新西兰重症监护学会中心结果和资源评估成人患者数据库中确定了 11327 例蛛网膜下腔出血患者。总病死率为 29.2%,从 2000 年的 35.4%降至 2015 年的 27.2%(p=0.01)。年龄较大、非手术入院、机械通气、较高的急性生理学和慢性健康评估 III 评分、较低的格拉斯哥昏迷量表评分以及 2004 年前入院均与多变量分析中的住院生存率降低相关(p<0.05)。与其他神经学诊断相比,蛛网膜下腔出血患者的风险调整后院内死亡率显著更高(优势比,1.89[95%置信区间,1.79-2.00])。利用最近 5 年(2010-2014 年)的完整数据,三个地点的标准化死亡率高于预期,而四个地点(包括两个最大的中心)的标准化死亡率低于预期。

结论

在澳大利亚和新西兰,入住 ICU 的蛛网膜下腔出血患者死亡率很高。2003 年以后的入院年份并未影响风险调整后的院内死亡率。机构之间存在显著差异。这意味着迫切需要系统地评估为该患者群体提供的重症监护的许多方面。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验